Dow component Johnson & Johnson fell 1.5% after U.S. regulators recommended a pause in using its single-dose COVID-19 vaccine to investigate reports of possibly dangerous blood clots. Moderna, which also makes a COVID-19 vaccine, rose 6.8%.
Long-term care associations are calling for the federal government to prioritize the vaccination of long-term care residents and staff after federal regulators suggested temporarily halting use of the Johnson & Johnson COVID-19 vaccine over concerns about blood clots.
For decades, a deadly type of childhood cancer has eluded science's best tools. Now doctors have made progress with an unusual treatment: Dripping millions of copies of a virus directly into kids' brains to infect their tumors and spur an immune system attack